118 related articles for article (PubMed ID: 16782070)
1. A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria.
Rawls SM; Rodriguez T; Baron DA; Raffa RB
Brain Res; 2006 Jul; 1099(1):82-7. PubMed ID: 16782070
[TBL] [Abstract][Full Text] [Related]
2. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2).
Rawls SM; Gomez T; Raffa RB
Pharmacol Biochem Behav; 2007 Mar; 86(3):499-504. PubMed ID: 17306870
[TBL] [Abstract][Full Text] [Related]
3. L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia.
Rawls SM; Tallarida RJ; Gray AM; Geller EB; Adler MW
J Pharmacol Exp Ther; 2004 Feb; 308(2):780-6. PubMed ID: 14610231
[TBL] [Abstract][Full Text] [Related]
4. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'.
Raffa RB; Stagliano GW; Ross G; Powell JA; Phillips AG; Ding Z; Rawls SM
Brain Res; 2008 Feb; 1193():51-6. PubMed ID: 18178175
[TBL] [Abstract][Full Text] [Related]
5. Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians.
Rawls SM; Gerber K; Ding Z; Roth C; Raffa RB
Synapse; 2008 Dec; 62(12):927-34. PubMed ID: 18792993
[TBL] [Abstract][Full Text] [Related]
6. Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose.
Umeda S; Stagliano GW; Raffa RB
Brain Res; 2004 Aug; 1018(2):181-5. PubMed ID: 15276876
[TBL] [Abstract][Full Text] [Related]
7. Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior.
González-Cuevas G; Aujla H; Martin-Fardon R; López-Moreno JA; Navarro M; Weiss F
Neuropsychopharmacology; 2007 Nov; 32(11):2260-6. PubMed ID: 17392740
[TBL] [Abstract][Full Text] [Related]
8. Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians.
Raffa RB; Stagliano GW; Tallarida RJ
Eur J Pharmacol; 2007 Feb; 556(1-3):89-90. PubMed ID: 17141755
[TBL] [Abstract][Full Text] [Related]
9. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal-like behavior in planarians is dependent on drug exposure duration.
Sacavage S; Patel H; Zielinski M; Acker J; Phillips AG; Raffa RB; Rawls SM
Neurosci Lett; 2008 Jul; 439(1):84-8. PubMed ID: 18511196
[TBL] [Abstract][Full Text] [Related]
11. Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria.
Raffa RB; Stagliano GW; Tallarida RJ
Brain Res; 2006 Oct; 1114(1):31-5. PubMed ID: 16914122
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats.
Uzbay IT; Erden BF; Tapanyigit EE; Kayaalp SO
Life Sci; 1997; 61(22):2197-209. PubMed ID: 9393939
[TBL] [Abstract][Full Text] [Related]
13. A role of nitric oxide in WIN 55,212-2 tolerance in mice.
Spina E; Trovati A; Parolaro D; Giagnoni G
Eur J Pharmacol; 1998 Feb; 343(2-3):157-63. PubMed ID: 9570463
[TBL] [Abstract][Full Text] [Related]
14. Cocaine withdrawal in Planaria.
Raffa RB; Valdez JM
Eur J Pharmacol; 2001 Oct; 430(1):143-5. PubMed ID: 11698074
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Cannabinoid Agonist, Heat Shock Protein 90 and Nitric Oxide Synthase Inhibitors on Increasing IL-13 and IL-31 Levels in Chronic Pruritus.
Todurga Seven ZG; Çakır Gündoğdu A; Ozyurt R; Özyazgan S
Immunol Invest; 2022 Oct; 51(7):1938-1949. PubMed ID: 35675220
[TBL] [Abstract][Full Text] [Related]
16. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring.
Shabani M; Hosseinmardi N; Haghani M; Shaibani V; Janahmadi M
Neuroscience; 2011 Jan; 172():139-52. PubMed ID: 20969930
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.
Aceto MD; Scates SM; Martin BB
Eur J Pharmacol; 2001 Mar; 416(1-2):75-81. PubMed ID: 11282115
[TBL] [Abstract][Full Text] [Related]
18. The Effects of the Heat Shock Protein 90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin, Cannabinoid Agonist WIN 55,212-2, and Nitric Oxide Synthase Inhibitor Nω-Nitro-L-Arginine Methyl Ester Hydrochloride on the Serotonin and Dry Skin-Induced Itch.
Todurga Seven ZG; Tombulturk FK; Gokdemir S; Ozyazgan S
Int Arch Allergy Immunol; 2022; 183(4):443-452. PubMed ID: 34864727
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism.
Buttarelli FR; Pontieri FE; Margotta V; Palladini G
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):65-8. PubMed ID: 11853121
[TBL] [Abstract][Full Text] [Related]
20. WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function.
Przegaliński E; Göthert M; Frankowska M; Filip M
Eur J Pharmacol; 2005 Jul; 517(1-2):68-73. PubMed ID: 15961074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
